MorphoSys

$22.36
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.19 (+0.86%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell MorphoSys and other stocks, options, and ETFs commission-free!

About MOR

MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research applications. It operates through the Proprietary Development and Partnered Discovery segments.

CEO
Jean-Paul Kress
Employees
615
Headquarters
Planegg, Bayern (Bavaria)
Founded
1992
Market Cap
2.93B
Price-Earnings Ratio
26.07
Dividend Yield
—
Average Volume
32.01K
High Today
$22.55
Low Today
$22.19
Open Price
$22.21
Volume
19.10K
52 Week High
$35.73
52 Week Low
$21.27

MOR Earnings

-$2.36
$0.67
$3.71
$6.74
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Available May 5, After Hours

You May Also Like

AMG
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure